These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18031328)

  • 21. Immunohistochemical detection of somatostatin receptors in human ovarian tumors.
    Schulz S; Schmitt J; Quednow C; Roessner A; Weise W
    Gynecol Oncol; 2002 Feb; 84(2):235-40. PubMed ID: 11812080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy.
    Mundschenk J; Unger N; Schulz S; Höllt V; Schulz S; Steinke R; Lehnert H
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5150-7. PubMed ID: 14602742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
    Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
    APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
    Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
    J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Apolipoprotein E immunoreactivity in normal and abnormal adrenal tissues].
    Umemori Y; Chiba H; Takahashi H; Matui H; Tokusashi Y; Miyokawa N
    Rinsho Byori; 1994 Sep; 42(9):977-80. PubMed ID: 7967124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of urocortin 3/stresscopin in human adrenal glands and adrenal tumors.
    Takahashi K; Totsune K; Saruta M; Fukuda T; Suzuki T; Hirose T; Imai Y; Sasano H; Murakami O
    Peptides; 2006 Jan; 27(1):178-82. PubMed ID: 16095756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin, cortistatin and their receptors in tumours.
    Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
    Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of somatostatin receptors 3, 4 and 5 in laryngeal pathology.
    Condon LT; Stafford ND; Bedford KJ; MacDonald AW; Atkin SL
    Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S63-7. PubMed ID: 18066572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues.
    Morimoto R; Satoh F; Murakami O; Totsune K; Arai Y; Suzuki T; Sasano H; Ito S; Takahashi K
    Peptides; 2008 May; 29(5):873-80. PubMed ID: 17686550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular biology, pharmacology and signal transduction of 5 cloned human somatostatin receptors].
    Fehmann HC; Arnold R
    Z Gastroenterol; 1996 Nov; 34(11):767-74. PubMed ID: 9045539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance.
    Reubi JC; Schaer JC; Markwalder R; Waser B; Horisberger U; Laissue J
    Yale J Biol Med; 1997; 70(5-6):471-9. PubMed ID: 9825475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas.
    Epelbaum J; Bertherat J; Prevost G; Kordon C; Meyerhof W; Wulfsen I; Richter D; Plouin PF
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1837-44. PubMed ID: 7775631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of somatostatin analogues in the treatment of neuroendocrine tumours.
    Grozinsky-Glasberg S; Grossman AB; Korbonits M
    Mol Cell Endocrinol; 2008 May; 286(1-2):238-50. PubMed ID: 18037561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precursor lesions of the adrenal gland.
    van Nederveen FH; de Krijger RR
    Pathobiology; 2007; 74(5):285-90. PubMed ID: 17890895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.
    de Bruin C; Feelders RA; Waaijers AM; van Koetsveld PM; Sprij-Mooij DM; Lamberts SW; Hofland LJ
    J Mol Endocrinol; 2009 Jan; 42(1):47-56. PubMed ID: 18852217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.
    Ławnicka H; Pisarek H; Kunert-Radek J; Pawlikowski M
    Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of FSH receptors in pituitary adenomas and adrenal tumors.
    Pawlikowski M; Pisarek H; Kubiak R; Jaranowska M; Stępień H
    Folia Histochem Cytobiol; 2012 Oct; 50(3):325-30. PubMed ID: 23042261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
    Kumar U
    J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
    de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
    Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.